REGENXBIO Inc. (RGNX) Stock News & Chart | StockAdder

(RGNX)

REGENXBIO Inc.

Stock chart and latest news for REGENXBIO Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

REGENXBIO Inc. News

PRO

REGENXBIO (RGNX) 2026 proxy details director votes, auditor, and stock option exchanges

Apr 14, 2026 GlobeNewswire

RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm

Apr 9, 2026 Yahoo Finance

REGENXBIO Inc. (RGNX): A Bull Case Theory

Jan 19, 2026 PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in REGENXBIO Inc. of Class Action Lawsuit and Upcoming Deadlines - RGNX

Apr 9, 2026 Investing.com

Pakola Steve, Regenxbio CMO, sells $53k in RGNX stock

Mar 12, 2026 simplywall.st

REGENXBIO Inc. (NASDAQ:RGNX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Feb 6, 2026 Seeking Alpha

Regenxbio stock drops on FDA setback for RGX-121 gene therapy (RGNX:NASDAQ)

Feb 10, 2026 NewMediaWire

Kaplan Fox Alerts Investors of REGENXBIO Inc. (RGNX) to an Investigation of Possible Securities Law Violations

Jan 28, 2026 PR Newswire

Investors who lost money on REGENXBIO Inc.(RGNX) should contact Levi & Korsinsky about pending Class Action - RGNX

Mar 11, 2026 Stock Titan

Vanguard (RGNX) disaggregates holdings; reports 0 shares after realignment

Mar 27, 2026 Yahoo Finance

Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported And Analysts Are Boosting Their Estimates

Nov 9, 2025 Investing.com

Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback